Hallervorden-Spatz disease is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Hallervorden-Spatz disease, or a subtype of Hallervorden-Spatz disease,
affects less than 200,000 people in the US population.
Source - National Institutes of Health (NIH)
Ophanet, a consortium of European partners,
currently defines a condition rare when it affects 1 person per 2,000.
They list Hallervorden-Spatz disease as a "rare disease".
Source - Orphanet
Hallervorden-Spatz disease: Introduction
Broader types of Hallervorden-Spatz disease:
Prevalance of Hallervorden-Spatz disease: rare
Prognosis of Hallervorden-Spatz disease: Poor. Death common within 10 years.
Complications of Hallervorden-Spatz disease:
see complications of Hallervorden-Spatz disease
Prognosis of Hallervorden-Spatz disease:
The
prognosis for individuals with Hallervorden-Spatz disease is poor. The
course of the disorder is relentlessly progressive. Death usually occurs
approximately 10 years after onset. In a few cases, survival may extend
for several decades.
(Source: excerpt from NINDS Hallervorden-Spatz Disease Information Page: NINDS)
Symptoms of Hallervorden-Spatz disease: see symptoms of Hallervorden-Spatz disease
Complications of Hallervorden-Spatz disease: see complications of Hallervorden-Spatz disease
Contagion of genetic conditions:
generally not; see details in contagion of genetic diseases.
Inheritance of genetic conditions: see details in inheritance of genetic diseases.
Misdiagnosis: see misdiagnosis and Hallervorden-Spatz disease.
Treatments for Hallervorden-Spatz disease:
see treatments for Hallervorden-Spatz disease
Research for Hallervorden-Spatz disease:
see research for Hallervorden-Spatz disease
Hospitalization statistics for Hallervorden-Spatz disease:
The following are statistics from various sources about hospitalizations and Hallervorden-Spatz disease:
Organs and body systems related to Hallervorden-Spatz disease include:
Main name of condition: Hallervorden-Spatz disease
Class of Condition for Hallervorden-Spatz disease: genetic
Pantothenate kinase-associated neurodegeneration, PKAN, Neurodegeneration with brain iron accumulation (NBIA), Neuroaxonal dystrophy, late infantile
Pantothenate kinase associated neurodegeneration, Pigmentary pallidal degeneration
Source - Diseases Database
Neuroaxonal dystrophy, late infantile, Neurodegeneration with brain iron accumulation (NBIA), PKAN, Pantothenate kinase-associated neurodegeneration
Source - Office of Rare Diseases (ORD) of the National Institutes of Health (NIH)
Research the causes of these diseases that are similar to, or related to, Hallervorden-Spatz disease:
What do you think about the features of this website? Take our user survey and have your say:
Next articles:
Tools & Services:
Medical Articles:
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.
"I authorize the release of any medical or other information necessary to process this claim." Do you recognize these words? You should, if...
Sexual contact can sometimes result in problems. An unwanted pregnancy or sexually transmitted diseases may be some of those consequences. But by...
Health insurance is important to everyone, especially people with chronic conditions like Crohn's disease and ulcerative colitis. Tune in to...
Sleep is necessary to feel refreshed, but now we know sleep actually impacts the way the body functions. Sleeping poorly can affect how often you get...